Metaba is a preclinical biopharmaceutical company utilizing innovative metabolomic technology to discover and develop life-saving therapies for patients. Initially focused on developing an adjunctive therapeutic for Tuberculosis (TB), Metaba has expanded its R&D efforts to include Covid-19, Nontuberculosis Mycobacteria (NTM), Atherosclerosis, Nonalcoholic Steatohepatitis (NASH), and Idiopathic Pulmonary Fibrosis (IPF) through ...
Metaba is a preclinical biopharmaceutical company utilizing innovative metabolomic technology to discover and develop life-saving therapies for patients. Initially focused on developing an adjunctive therapeutic for Tuberculosis (TB), Metaba has expanded its R&D efforts to include Covid-19, Nontuberculosis Mycobacteria (NTM), Atherosclerosis, Nonalcoholic Steatohepatitis (NASH), and Idiopathic Pulmonary Fibrosis (IPF) through collaborations with global pharmaceutical companies and research institutions.
Sponsored Ad
Upload your Marketing & Sales content on your company Virtual Booth, click HERE.